Clinical trial
To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects…
NCT00150358 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00150358 |
|---|---|
| Title | To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension . |
| Official title | Open Label, Multicenter, Non Comparative Study, To Confirm The Efficacy And Tolerability Of Viagra In Subjects With Erectile Dysfunction And Arterial Hypertension Who Are Taking Antihypertensive Treatment. |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Impotence, Hypertension |
| Intervention type | Drug |
| Interventions | Sildenafil Citrate |
| Enrollment | 253 |
| Start date | Mar 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 1, 2021 |
| Countries | Mexico |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: